P-Tau231

The ability of plasma P-tau231 to detect preclinical Alzheimer’s disease

Differences between Alzheimer’s disease biomarkers: p-Tau181, p-Tau231 & p-Tau217

Value of p-tau231 in early Alzheimer’s disease

Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer's

Investigating novel plasma-based P-tau biomarkers

Biomarkers for risk assessment and early diagnosis of AD

Prognostic blood biomarkers in the pre-clinical stages of Alzheimer’s disease

Upcoming plasma biomarkers for Alzheimer’s disease: Aβ, p-tau and GFAP

Comparing the performance of novel biomarkers across the spectrum of Alzheimer’s disease

Head-to-head comparison of p-tau species for Alzheimer’s disease detection in a real-world cohort

Latest knowledge on plasma p-tau in Alzheimer’s disease

Blood biomarkers for the differential diagnosis of Alzheimer’s disease in clinical practice

Alzheimer’s disease plasma biomarkers across the spectrum: which perform best?

Biomarkers for Alzheimer’s disease in a preclinical setting

Plasma p-tau as a biomarker for cerebral amyloid angiopathy diagnosis

Examining plasma vs. CSF p-tau217 in preclinical and prodromal Alzheimer’s disease

Quanterix Top 5 2021 AAIC Abstracts

What do we understand about the secretion of brain p-tau in AD?

Potential markers for alzheimer’s disease: Plasma p-tau181/Aβ1-42

Medical Dialogues